We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.05
Bid: 7.80
Ask: 8.30
Change: 0.05 (0.63%)
Spread: 0.50 (6.41%)
Open: 8.25
High: 8.25
Low: 8.05
Prev. Close: 8.00
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Salarius Appoints CEO

29 Dec 2021 07:00

RNS Number : 8615W
Tekcapital plc
29 December 2021
 

29 December 2021

Tekcapital Plc

("Tekcapital", the "Company" or "the Group")

 

Portfolio Company Update: Salarius, Ltd. ("Salarius")

Appointment of Rick Guiney as CEO of MicroSalt Inc.

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products from investing in university technology that can improve people's lives, is pleased to announce that Salarius' U.S. subsidiary MicroSalt Inc. (MicroSalt) has appointed Rick Guiney as CEO.

 

Rick has more than 35 years of experience in the food industry, including 30+ years as President & CEO of Classic Snacks, Inc., where he pioneered the ground-up development of the business and transformed it into a market-leading direct distribution company in the food industry. Classic Snacks was included on the Inc. 500 Fastest Growing Company List, and quickly became a nationwide snack food packager and distributor to airlines, restaurants, hotels, country clubs, bars, taverns, and retail private label customers. Rick also served as Foodservice Business Manager for Quorn Foods in the United States.

 

"I'm thrilled to be joining this successful, rapidly growing enterprise as it enters what I believe to be a significant period of accelerated growth. MicroSalt® is committed to making an impact on cardiovascular disease by reducing excess sodium consumption. The recently announced FDA sodium reduction guidelines, the placement of our low-sodium full-flavour SaltMe! Chips with the largest supermarket in the U.S., and the receipt of two international awards (P&G Alumni Star Entrepreneur Award and the GHP Fitness & Nutrition award, for the best low sodium salt in 2021) all point to the same conclusion: the need and market for MicroSalt is both immediate and global, " said Rick Guiney, CEO of MicroSalt®.

 

"We are very excited about the future potential of MicroSalt and the positive impact it can make by enabling "better for you" snacks with reduced sodium. We want to express our gratitude to Victor Manzanilla for his leadership of MicroSalt during its formative stage, and we are glad that he will continue to guide the company as a member of its expanded board of directors," said Clifford M. Gross, Ph.D., CEO of Tekcapital.

 

About Salarius Ltd. and MicroSalt, Inc.

Salarius, is the developer and manufacturer of a proprietary low-sodium salt called MicroSalt®. We are passionate about improving peoples' lives by providing the best low-sodium salt, based on the mechanical transformation of the salt particle itself. MicroSalt, Inc., Salarius' U.S. operating subsidiary, aims to revolutionize the food industry with its patented better-for-you salt, that delivers the full-flavour experience of salt with roughly half the sodium. MicroSalt® is all-natural, non-GMO, and Kosher. Additionally, the ultra-small particle size enhances product adhesion, which reduces waste and provides improved flavour consistency. MicroSalt® and SaltMe® are registered trademarks of MicroSalt Inc. To learn more about MicroSalt please visit https://Salarius.co/. 

To learn more about SaltMe! snacks please visit https://saltme.com/.

 

Tekcapital owns 97.2% of the share capital of Salarius Ltd. and approximately 87% of the share capital of MicroSalt Inc., its U.S. subsidiary.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc 

Via Flagstaff IR

Clifford M. Gross, Ph.D. 

SP Angel  Corporate Finance LLP (Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 

 

Flagstaff Strategic and Investor Communications +44 (0)207 129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Salarius that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Salarius' and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Salarius or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither Salarius nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAVVLFLFLLXFBB
Date   Source Headline
26th Oct 202111:05 amRNSSecond Price Monitoring Extn
26th Oct 202111:00 amRNSPrice Monitoring Extension
19th Oct 20218:00 amRNSLucyd Proposed IPO in the United States
19th Oct 20217:00 amRNSLucyd Update
14th Oct 202111:05 amRNSSecond Price Monitoring Extn
14th Oct 202111:00 amRNSPrice Monitoring Extension
14th Oct 20217:00 amRNSSalarius FDA Sodium Reduction Goals
8th Oct 20218:59 amRNSSaltMe Roll out in leading US Supermarket Chain
29th Sep 20212:17 pmRNSLucyd Distribution Growth
20th Sep 20214:41 pmRNSSecond Price Monitoring Extn
20th Sep 20214:36 pmRNSPrice Monitoring Extension
10th Sep 202111:30 amRNSNotification of Major Shareholding
31st Aug 20217:00 amRNSLucyd Update
24th Aug 20217:00 amRNSLucyd Non Executive Director Appointment
20th Aug 20219:05 amRNSSecond Price Monitoring Extn
20th Aug 20219:00 amRNSPrice Monitoring Extension
16th Aug 20217:00 amRNSRecord Half Year Results for period to 31 May 2021
5th Aug 20212:59 pmRNSHolding(s) in Company
5th Aug 20211:44 pmRNSNotification of Major Holding
5th Aug 20217:00 amRNSLucyd Appoints Non Executive Director
22nd Jul 20217:00 amRNSLucyd launches Crowdfund
5th Jul 202112:37 pmRNSNotification of Major Holdings
5th Jul 20217:00 amRNSLucyd Signs Canadian Distribution Agreement
1st Jul 20217:00 amRNSNotification of Investor Presentation
15th Jun 20212:05 pmRNSSecond Price Monitoring Extn
15th Jun 20212:00 pmRNSPrice Monitoring Extension
15th Jun 20217:00 amRNSGrant of Share Options
8th Jun 20217:00 amRNSNotice of Investor Presentation 8 June 2021
28th May 202110:40 amRNSResults of Annual General Meeting
28th May 20217:12 amRNSBelluscura First Day of Dealings on AIM
13th May 20217:00 amRNSNotice of AGM
10th May 20217:00 amRNSInvestor Presentation
7th May 20214:41 pmRNSSecond Price Monitoring Extn
7th May 20214:36 pmRNSPrice Monitoring Extension
7th May 20217:15 amRNSBelluscura Intention to Float on AIM
5th May 20217:00 amRNSPortfolio Company Update - Lucyd
4th May 20217:00 amRNSPortfolio Company Update - Guident
30th Apr 20217:00 amRNSFinal Results
1st Apr 20217:00 amRNSPortfolio Company Lucyd Update
31st Mar 20217:00 amRNSTotal Voting Rights
25th Mar 20217:00 amRNSNotification of Major Holdings
22nd Mar 20211:43 pmRNSNotification of Major Holdings
22nd Mar 20217:00 amRNSLucyd Signs Distribution Agreement
19th Mar 20214:21 pmRNSNotification of Major Holdings
19th Mar 202112:36 pmRNSNotification of Major Holdings
18th Mar 20219:05 amRNSSecond Price Monitoring Extn
18th Mar 20219:00 amRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSPlacing to raise £3.8 million
11th Mar 20217:00 amRNSSalarius update
8th Mar 20217:00 amRNSBelluscura FDA Clearance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.